As part of the deal, Lupin will pay Zydus upfront licensing fees and milestone-based payments linked to predefined targets.
March 17 (Reuters) - Indian drugmakers Zydus Lifesciences and Lupin have signed a licensing and supply deal on Tuesday to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results